U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Enhancing Adoption of Innovative Clinical Trial Approaches - 03/19/2024
  1. News & Events for Human Drugs

Public | Mixed

Event Title
Enhancing Adoption of Innovative Clinical Trial Approaches
March 19 - 20, 2024

Date:
March 19 - 20, 2024
Day1:
Tue, Mar 19
Day2:
Wed, Mar 20

The U.S. Food and Drug Administration and the Duke-Margolis Center for Health Policy will convene a hybrid public workshop on March 19 and 20, 2024, to discuss efforts to advance innovation of clinical trial design and conduct. CDER’s portfolio of clinical trial innovation activities are wide ranging and span across drug development programs, therapeutic areas, and scientific disciplines.

Workshop Objectives

Stakeholders will discuss barriers and challenges to incorporating successful or promising innovative clinical trial approaches in drug development.

The workshop will discuss:

  • Regulatory and Compliance Considerations
  • Patient-Centricity and Recruitment Innovations
  • Clinical Trial Infrastructure and Organizational Culture

For more information and to register for the workshop, please visit the Duke-Margolis event webpage.

Back to Top